MetaCap

Humana (HUM) vs Labcorp (LH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Humana (HUM) has outperformed Labcorp (LH) over the past year, gaining 71.7% versus a gain of 38.2%. Over five years, LH leads with a +47.7% price change compared with -9.0% for HUM. Humana is the larger company by market cap ($46.84 billion vs $29.81 billion), about 1.6 times the size.

On valuation, Labcorp trades at a lower forward P/E (18.7x vs 21.1x for Humana). Humana offers the higher dividend yield (0.91% vs 0.78%). Labcorp converts more of its revenue into profit, with a net margin of 6.3% versus 0.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HUM+71.73%LH+38.21%
+110%+38%-34%
Nov 21, 20251 yearNov 20, 2026
HUM-10.32%LH+50.83%
+58%-5%-68%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HUM versus LH key metrics
MetricHUMLH
Share price$390.00$367.13
Market cap$46.84B$29.81B
1-day change+2.63%-0.47%
YTD return+52.27%+46.34%
1-year return+71.73%+38.21%
5-year return-8.98%+47.71%
P/E ratio (TTM)38.0530.09
Forward P/E21.0618.73
EPS (TTM)$10.25$12.20
Dividend yield0.91%0.78%
Annual dividend$3.54$2.88
Revenue (latest FY)$129.66B$13.95B
Revenue growth (YoY)+10.11%+7.25%
Net income (latest FY)$1.19B$876.50M
Gross margin—28.76%
Operating margin2.09%9.92%
Net margin0.92%6.28%
52-week high$462.87$375.10
52-week low$163.11$245.00
Distance from 52-week high-15.74%-2.12%
Analyst consensusbuybuy
Avg. price target upside+30.98%+6.25%
Average volume1.46M744.44K
Shares outstanding120.10M81.20M
Employees67,06071,000
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HUM has outperformed LH by 33.5 percentage points over the past year.
  • Humana trades at a higher earnings multiple (38.0x vs 30.1x trailing P/E).
  • Labcorp is more profitable, keeping 6.3 cents of every revenue dollar as net income versus 0.9 cents for Humana.

About Humana

HUM stock →

Humana Inc. provides medical and specialty insurance products in the United States.

Health Care · Medical Specialities · 67,060 employees

About Labcorp

LH stock →

Labcorp Holdings Inc. provides laboratory services.

Health Care · Medical Specialities · 71,000 employees

HUM vs LH FAQ

Which is bigger, Humana or Labcorp?

Humana (HUM) is larger, with a market capitalization of $46.84B compared with $29.81B for Labcorp (LH).

Which stock has performed better over the past year, HUM or LH?

HUM returned +71.73% over the past 12 months, compared with +38.21% for LH (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, HUM or LH?

LH has the lower trailing P/E at 30.1, versus 38.0 for HUM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Humana or Labcorp?

Humana has the higher yield at 0.91%, compared with 0.78% for Labcorp.

Are Humana and Labcorp in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons